E N D
1. Fever of Unknown Originand Adult Onset Still’s Disease (AOSD) AM Report
Eric Edwards, M.D.
September 4, 2007
3. Fever of Unknown Origin: Definition NOT febrile illness without initially obvious etiology
“Classical” definition (Petersdorf and Beeson, 1961):
Fever > 38.3 on several occasions
Duration>3 weeks
Failure to reach a diagnosis after one week of inpatient investigation*
4. Patient Subtypes Classical
Nosocomial (Hospitalized>24h, no fever PTA)
C. Difficile, PE, drugs
Immune Deficient (ANC<500)
Bacteremia, Fungal, HSV
HIV
M. Avium, PCP, CMV, lymphoma, Kaposi’s, drugs
5. Differential Diagnosis Infections
Malignancies
Autoimmune Disease
Miscellaneous
Drugs
Hepatitis
DVT
8. Causes of FUO(in India) Infectious 53%
#1: TB (45%)
Neoplasm: 17%
#1: NHL (47%)
Collagen Vasc.: 11%
#1 SLE: 45%
Miscellaneous: 5%
Undiagnosed: 14%
9. FUO by the Decades
10. Minimal Diagnostic Criteria
H+P
CBC & Diff
Blood Cultures x 3
Chem10
LFTs
U/A and Microscopy
Urine culture
Chest X-ray
Hepatitis serologies (if abnormal LFTs)
11. Other Basic Tests ESR/CRP
Peripheral Smear
ANA
Rheumatoid Factor
HIV
CMV IgM
Mono Spot
PPD
12. Imaging Abdominal CT
Chest CT
Nuclear Imaging
Lower Extremity Dopplers
TTE/TEE
13. Invasive Procedures Lumbar Puncture
Liver Biopsy
Temporal Artery Biopsy
Bone Marrow Biopsy
Lymph Node Biopsy
Surgical Exploration of the Abdomen
15. Adult Onset Still’s Disease Epidemiology
Rare (0.16/100000)
~60% female
Affects all ages
Pathogenesis
Poorly understood
Genetic component?
Infectious trigger?
Characteristics
Daily, high spiking fevers (85-100%)
Arthritis (68-94%)
Evanescent rash (51-87%)
No specific diagnostic study
Diagnosis is based on the presentation of characteristic features and the exclusion of similar conditions
17. Diagnostic Criteria (Yamaguchi) Major
Fever>39°, lasting >1 week
Arthralgias or arthritis lasting >2 weeks
Typical rash
WBC>10,000 with >80% PMNs
Minor
Sore throat
Lymphadenopathy and/or splenomegaly
Abnormal LFTs
Negative ANA and RF
Exclusions
Infections
Malignancy
Rheumatic Disease
18. AOSD and Ferritin Ferritin is an acute phase reactant
80% have >5x elevation in ferritin
Non-specific
Low Glycosylated ferritin (GF) is more specific
GF<20% + Ferritin >5x nl=93% specific
Only 43% sensitive
19. Treatment NSAIDs
Monotherapy is effective in only ~10%
Steroids
75% will respond favorably
Methotrexate
TNF blocking agents
Etanercept
Infliximab
20. Prognosis Three distinct patters (~1:1:1)
Self limited
Most patients achieve remission within one year
Intermittent
Recurrent flares with complete remission between
Flares may be years apart
Recurrences tend to be milder than initial episode
Chronic
Articular manifestations can be severe
2/3 may need at least one total joint replacement
21. References 1. Roth AR et al. Approach to the Patient with Fever of Unknown Origin. Am Fam Physician. 2003 Dec 1;68(11):2223-28.
2. Mourad O et al. A Comprehensive Evidence Based Approach to Fever of Unknown Origin. Arch Int Med. 2003 Mar 10;163:545-51.
3. Bor, DH. Approach to the Adult with Fever of Unknown Origin. www.utdol.com.
4. Kejariwal D et al. Pyrexia of Unknown Origin: A Prospective Study of 100 Cases. J Postgrad Med. 2002 Apr-Jun;48(2):155-6.
5. Efthimiou P et al. Diagnosis and Management of Adult Onset Still’s Disease. Ann Rheum Dis. 2006 May;65:564-72.
6. Uppal SS et al. Ten Years of Clinical Experience with Adult Onset Still’s Disease: Is the Outcome Improving? Clin Rheumatol. 2007 Jul;26(7):1055-60.